Desloratadine in the treatment of seasonal allergic rhinitis: Results of a large observational study

Clinical Drug Investigation

Volumn 22, Issue SUPPL. 2, 2002, Pages 43-52

  Bachert, Claus ^a   Virchow Jr , Christian J ^a   Plenker, Astrid ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; DESLORATADINE; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GERMANY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBSERVATION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SIDE EFFECT; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0036327999     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222002-00005     Document Type: Article

References (28)

1. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
2. Measuring quality of life in children with rhinoconjunctivitis
3. Learning impairment and allergic rhinitis
4. Desloratadine reduces nasal congestion in SAR with greater magnitude than fexofenadine, cetirizine and loratadine
5. Nasal obstruction as a risk factor for sleep-disordered breathing
6. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study
7. Overview of comorbid associations of allergic rhinitis
8. Relationships between rhinitis and asthma
9. Molecular and cellular mechanisms of allergic disease
10. Allergy and allergic diseases (part 1 of 2)
11. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist, 1st communication: Receptor selectivity, antihistaminic activity, and antiallergic effects
12. Efficacy and tolerability of once-daily desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis
13. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study
14. Desloratadine: A new, nonsedating, oral antihistamine
15. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis
16. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis
17. Desloratadine reduces nasal congestion and maintains nasal airflow in patients with seasonal allergic rhinitis exposed to allergen in the Vienna Challenge Chamber
18. The pharmacologic profile of desloratadine: A review
19. Bayer decides to withdraw cholesterol lowering drug
20. Withdrawal of troglitazone and cisapride
21. The safety of newly approved medicines: Do recent market removals mean there is a problem?
22. Torsade de pointes induced by terfenadine in a patient with long QT syndrome
23. Desloratadine improved asthma symptoms and decreased β2 agonist use in patients with seasonal allergic rhinitis and asthma
24. Cetirizine in patients with seasonal rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial
25. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
26. Allergic rhinitis and its impact on asthma